Levosimendan in Septic Shock: Another Piece in the Puzzle, but Many Pieces Are Still Lacking

Overview

Journal Intensive Care Med

Specialty Critical Care

Date 2007 Jan 31

PMID 17262189

Citations 2

Authors

Daniel De Backer

Fabio Silvio Taccone

Peter Radermacher

Affiliations

Soon will be listed here.

Citing Articles

Ventriculo-arterial decoupling in acutely altered hemodynamic states.

Guarracino F, Baldassarri R, Pinsky M Crit Care. 2013; 17(2):213.

PMID: 23510336 PMC: 3672525. DOI: 10.1186/cc12522.

The effects of levosimendan and glibenclamide on circulatory and metabolic variables in a canine model of acute hypoxia.

Schwarte L, Schwartges I, Thomas K, Schober P, Picker O Intensive Care Med. 2011; 37(4):701-10.

PMID: 21380525 PMC: 3058361. DOI: 10.1007/s00134-011-2144-1.

References

Noto A, Giacomini M, Palandi A, Stabile L, Reali-Forster C, Iapichino G . Levosimendan in septic cardiac failure. Intensive Care Med. 2004; 31(1):164-5. DOI: 10.1007/s00134-004-2502-3. View

Sakr Y, Dubois M, De Backer D, Creteur J, Vincent J . Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004; 32(9):1825-31. DOI: 10.1097/01.ccm.0000138558.16257.3f. View

Vogt J, Reinelt H, Radermacher P . Dobutamine and the oxygen uptake/supply relationship in sepsis: from global to regional--nothing is simple and easy. Intensive Care Med. 1997; 23(7):715-7. DOI: 10.1007/s001340050399. View

Ruokonen E, Uusaro A, Alhava E, Takala J . The effect of dobutamine infusion on splanchnic blood flow and oxygen transport in patients with acute pancreatitis. Intensive Care Med. 1997; 23(7):732-7. DOI: 10.1007/s001340050401. View

Korvald C, Elvenes O, Myrmel T . Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol. 2000; 278(4):H1345-51. DOI: 10.1152/ajpheart.2000.278.4.H1345. View

Kopustinskiene D, Pollesello P, Saris N . Levosimendan is a mitochondrial K(ATP) channel opener. Eur J Pharmacol. 2001; 428(3):311-4. DOI: 10.1016/s0014-2999(01)01350-4. View

Kopustinskiene D, Pollesello P, Saris N . Potassium-specific effects of levosimendan on heart mitochondria. Biochem Pharmacol. 2004; 68(5):807-12. DOI: 10.1016/j.bcp.2004.05.018. View

De Backer D, Creteur J, Dubois M, Sakr Y, Koch M, Verdant C . The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med. 2006; 34(2):403-8. DOI: 10.1097/01.ccm.0000198107.61493.5a. View

De Backer D, Creteur J, Noordally O, Smail N, Gulbis B, Vincent J . Does hepato-splanchnic VO2/DO2 dependency exist in critically ill septic patients?. Am J Respir Crit Care Med. 1998; 157(4 Pt 1):1219-25. DOI: 10.1164/ajrccm.157.4.9705075. View

10.

Morelli A, De Castro S, Teboul J, Singer M, Rocco M, Conti G . Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med. 2005; 31(5):638-44. DOI: 10.1007/s00134-005-2619-z. View

11.

Nuckton T, Alonso J, Kallet R, Daniel B, Pittet J, Eisner M . Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med. 2002; 346(17):1281-6. DOI: 10.1056/NEJMoa012835. View

12.

Asfar P, De Backer D, Meier-Hellmann A, Radermacher P, Sakka S . Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock. Crit Care. 2004; 8(3):170-9. PMC: 468887. DOI: 10.1186/cc2418. View

13.

Schwarte L, Picker O, Bornstein S, Fournell A, Scheeren T . Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs. Crit Care Med. 2005; 33(1):135-42. DOI: 10.1097/01.ccm.0000150653.89451.6f. View

14.

Behrends M, Peters J . The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts. Intensive Care Med. 2003; 29(10):1802-7. DOI: 10.1007/s00134-003-1879-8. View

15.

Riddez L, Hahn R, BRISMAR B, Strandberg A, Svensen C, Hedenstierna G . Central and regional hemodynamics during acute hypovolemia and volume substitution in volunteers. Crit Care Med. 1997; 25(4):635-40. DOI: 10.1097/00003246-199704000-00013. View

16.

Morelli A, Teboul J, Maggiore S, Vieillard-Baron A, Rocco M, Conti G . Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med. 2006; 34(9):2287-93. DOI: 10.1097/01.CCM.0000230244.17174.4F. View

17.

Faivre V, Kaskos H, Callebert J, Losser M, Milliez P, Bonnin P . Cardiac and renal effects of levosimendan, arginine vasopressin, and norepinephrine in lipopolysaccharide-treated rabbits. Anesthesiology. 2005; 103(3):514-21. DOI: 10.1097/00000542-200509000-00014. View

18.

De Backer D, Creteur J, Preiser J, Dubois M, Vincent J . Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002; 166(1):98-104. DOI: 10.1164/rccm.200109-016oc. View

19.

Matejovic M, Krouzecky A, Radej J, Novak I . Successful reversal of resistent hypodynamic septic shock with levosimendan. Acta Anaesthesiol Scand. 2005; 49(1):127-8. DOI: 10.1111/j.1399-6576.2005.00541.x. View

20.

Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B . Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2002; 345(19):1368-77. DOI: 10.1056/NEJMoa010307. View